Hydrocolloid Dressings in Diaper Dermatitis (NCT07186907) | Clinical Trial Compass
CompletedNot Applicable
Hydrocolloid Dressings in Diaper Dermatitis
Turkey (Türkiye)44 participantsStarted 2017-11-13
Plain-language summary
Diaper dermatitis (commonly known as diaper rash) is one of the most frequent skin problems in newborns and infants, especially in neonatal intensive care units (NICUs). This study was designed to compare two treatment approaches for diaper dermatitis: hydrocolloid dressings and a cream containing 40% zinc oxide. The severity of diaper rash was evaluated at the beginning of treatment and at 24, 48, and 72 hours of follow-up.
Who can participate
Age range
0 Days – 1 Year
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Hospitalization in the NICU
* Body weight greater than 1000 g at the start of the intervention
* Gestational age above 26 weeks
* Diaper dermatitis diagnosis confirmed by a clinician
* Clinically stable condition at enrollment
* Written informed consent obtained from parents or legal guardians
Exclusion Criteria:
* Congenital skin anomalies
* Dermatitis due to other dermatological conditions
* Systemic bacterial or fungal infections
* Receiving immunosuppressive treatment
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in diaper dermatitis severity score
Timeframe: Baseline, 24 hours, 48 hours, and 72 hours after initiation of intervention.
2
Time to complete healing of diaper dermatitis
Timeframe: Within 72 hours after initiation of intervention.